🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
XEN
$XENE
🔒 US EquitiesXenon Pharmaceuticals Inc
AVG HISTORICAL GAP
-0.91%
MAX GAP RECORD
-9.97%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $XENE
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$XENE
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 02, 2026 Earnings Release 2026-11-02 (AFTER CLOSE (21:00)) | 🔮 UPCOMING 🔒 |
| Aug 06, 2026 Earnings Release 2026-08-06 (AFTER CLOSE) |
-2.40%
|
| May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE) |
+0.23%
|
| Feb 26, 2026 Earnings Release 2026-02-26 (AFTER CLOSE) |
+1.07%
|
| Nov 03, 2025 Earnings Release 2025-11-03 (AFTER CLOSE) |
-3.36%
|
| Aug 11, 2025 Earnings Release 2025-08-11 (AFTER CLOSE) |
+5.54%
|
| May 12, 2025 Earnings Release 2025-05-12 (AFTER CLOSE) |
-8.48%
|
| Feb 27, 2025 Earnings Release 2025-02-27 (AFTER CLOSE) |
-3.42%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.5%
Bullish Gaps (6)
Bearish Gaps (6)
Neutral / Flat (3)
📖 Intelligence Summary
Xenon Pharmaceuticals, Inc. is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗